QBeyond (QBY.DE) stock: key figures, P/E, revenue and dividend
Communication Services · Germany · ISIN DE0005137004
QBeyond financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 192.00 m EUR | 182.00 m EUR |
| Gross profit | 36.00 m EUR | 36.00 m EUR |
| Operating income | -2.52 m EUR | -842,000.00 EUR |
| EBIT | -2.00 m EUR | -2.00 m EUR |
| Net income | -4.95 m EUR | 1.48 m EUR |
| Diluted EPS – continuing operations | -0.20 EUR | 0.06 EUR |
Full history since 2002, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About QBeyond
q.beyond AG engages in the cloud, applications, artificial intelligence (AI), and security business in Germany and internationally. It operates through two segments, Consulting and Managed Services. The Consulting segment provides various consulting and customized development services; support customers using SAP and Microsoft solutions; security services; and business intelligence solutions, as well as supply solutions in the form of mobile and cloud-based applications. The Managed Services segment offers turnkey cloud modules; digital workplaces facilitating networked mobile work; and individual IT outsourcing services, as well as turnkey colocation solutions at its data centres. It serves medium-sized companies. The company was formerly known as QSC AG and changed its name to q.beyond AG in September 2020. q.beyond AG was founded in 1997 and is headquartered in Cologne, Germany.
More stocks
- Unison Co. Ltd (018000.KQ)
- Pacific Hospital Supply Co Ltd (4126.TWO)
- Bakkt, Inc. (BKKT)
- Vireo Growth Inc. (VREOF)
- Crexendo, Inc. (CXDO)
- Seoul City Gas (017390.KS)
- Dafeng TV Ltd (6184.TW)
- Humacyte, Inc. (HUMA)
- Sriracha Construction Public Company Limited (SRICHA.BK)
- Zentalis Pharmaceuticals, Inc. (ZNTL)
- VANJIA CORP (VNJA)
- Benfica (SLBEN.LS)
Not investment advice. All data without warranty, price as of 10.09.2026. Details in the risk notice.